| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 4.895 | 5.576 | 114 | 0 | 2.479 | 11.704 | 25.640 |
| Total Income - EUR | - | - | 0 | 4.895 | 5.576 | 114 | 0 | 2.479 | 11.704 | 25.640 |
| Total Expenses - EUR | - | - | 523 | 3.414 | 6.488 | 551 | 0 | 1.784 | 6.419 | 23.746 |
| Gross Profit/Loss - EUR | - | - | -523 | 1.481 | -912 | -437 | 0 | 695 | 5.285 | 1.894 |
| Net Profit/Loss - EUR | - | - | -523 | 1.334 | -1.080 | -441 | 0 | 621 | 4.454 | 1.140 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Medsant G&V S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 8 | 1.054 | 824 | 602 | 588 | 953 | 633 | 17.420 |
| Current Assets | - | - | 95 | 659 | 351 | 80 | 98 | 661 | 4.796 | 3.084 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 155 | 1.311 | 1.376 |
| Cash | - | - | 95 | 659 | 351 | 80 | 98 | 506 | 3.486 | 1.708 |
| Shareholders Funds | - | - | -857 | 493 | -597 | -1.026 | -983 | -365 | 4.090 | 5.208 |
| Social Capital | - | - | 22 | 21 | 21 | 21 | 40 | 41 | 40 | 40 |
| Debts | - | - | 961 | 1.221 | 1.771 | 1.707 | 1.670 | 1.979 | 1.339 | 15.737 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medsant G&V S.r.l.